prednisolon "unimedic" 31,25 mg rektalvæske, opløsning
unimedic pharma ab - prednisolonnatriumphosphat - rektalvæske, opløsning - 31,25 mg
melatonin "unimedic pharma" 1 mg/ml oral opløsning
unimedic pharma ab - melatonin - oral opløsning - 1 mg/ml
oxybutynin "unimedic" 0,5 mg/ml intravesikal opløsning
unimedic pharma ab - oxybutyninhydrochlorid - intravesikal opløsning - 0,5 mg/ml
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
cardiospir plus 10+25 mg filmovertrukne tabletter
uni-pharma kleon - bisoprololfumarat, hydrochlorthiazid - filmovertrukne tabletter - 10+25 mg
cardiospir plus 5+12,5 mg filmovertrukne tabletter
uni-pharma kleon - bisoprololfumarat, hydrochlorthiazid - filmovertrukne tabletter - 5+12,5 mg
medithyrox 112 mikrogram tabletter
uni-pharma kleon - levothyroxinnatrium - tabletter - 112 mikrogram
medithyrox 125 mikrogram tabletter
uni-pharma kleon - levothyroxinnatrium - tabletter - 125 mikrogram
medithyrox 137 mikrogram tabletter
uni-pharma kleon - levothyroxinnatrium - tabletter - 137 mikrogram
medithyrox 150 mikrogram tabletter
uni-pharma kleon - levothyroxinnatrium - tabletter - 150 mikrogram